FDA NDC Directory · JSON-LD · Markdown

ENZEEVU

NDC 61314-504 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameaflibercept
Labeler / ManufacturerSandoz Inc
Marketing categoryBiologic License Application · App BLA761382
Dosage form / routeINJECTION, SOLUTION · INTRAVITREAL
Active ingredientsAFLIBERCEPT (2 mg/.05mL)
Marketing started20261026
Package count1

External sources

Source: openFDA. Public-domain (CC0).